The proposed UK assisted dying law may be delayed until 2029, raising doubts about its future. Novo Nordisk's shares tumble ...

The Business Research Company Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout. LONDON, GREATER ...

The president has said the levies will be “lenient,” but money managers are on guard given the lack of specifics around what the next package of tariffs may include. In a hint of the potential ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Novo Nordisk’s bid to provide a once-weekly basal ... but comes after insulin icodec has already been approved in the EU, Canada, Australia, Japan, and Switzerland under the Awiqli brand name ...

Vivani Medical, Inc. (NASDAQ:VANI), on Wednesday, released preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic weight management in obese and overweight ...

Novo Nordisk's anti-TFPI antibody concizumab has ... Alhemo – is already approved in other markets, including Japan, Australia, and Switzerland, but was rejected by the FDA last year with ...

Globally, the rate of death from chronic kidney disease increased 24% from 1990 to 2021, according to statistics published by ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

Companies like SAP and BYD, despite enjoying a good run so far this year, may be unable to escape the turmoil if the U.S.

GBTEC, a leading SaaS provider in AI-powered business transformation, extends its BIC Platform with the fully integrated BIC EAM component. With this addition, GBTEC strengthens its long-standing EAM ...

Millions of customers, one goal: making loyalty smarter, simpler, and more rewarding than ever before. EG America, LLC, one of the largest and fastest growing convenience store operators in the U.S., ...